v3.24.1.u1
CONSOLIDATED STATEMENT OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Operating Activities    
Net loss $ (955) $ (1,060)
Adjustments to reconcile net income to cash provided by (used in) operating activities:    
Content rights amortization and impairment 3,827 4,723
Depreciation and amortization 1,888 2,058
Deferred income taxes (399) (669)
Share-based compensation expense 101 111
Equity in losses of equity method investee companies and cash distributions 58 62
Gain from derivative instruments, net (43) (23)
Other, net 7 97
Changes in operating assets and liabilities, net of acquisitions and dispositions:    
Receivables, net (304) (486)
Film and television content rights, games, and production payables, net (2,778) (4,051)
Accounts payable, accrued liabilities, deferred revenues and other noncurrent liabilities (753) (1,652)
Foreign currency, prepaid expenses and other assets, net (64) 259
Cash provided by (used in) operating activities 585 (631)
Investing Activities    
Purchases of property and equipment (195) (299)
Investments in and advances to equity investments (53) (13)
Other investing activities, net 41 55
Cash used in investing activities (207) (257)
Financing Activities    
Principal repayments of term loans 0 (1,500)
Principal repayments of debt, including premiums and discounts to par value (1,047) (106)
Borrowings from debt, net of discount and issuance costs 0 1,500
Distributions to noncontrolling interests and redeemable noncontrolling interests (130) (237)
Borrowings under commercial paper program and revolving credit facility 2,200 932
Repayments under commercial paper program and revolving credit facility (2,200) (933)
Other financing activities, net (60) (88)
Cash used in financing activities (1,237) (432)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (74) 29
Net change in cash, cash equivalents, and restricted cash (933) (1,291)
Cash, cash equivalents, and restricted cash, beginning of period 4,319 3,930
Cash, cash equivalents, and restricted cash, end of period $ 3,386 $ 2,639